Adult Cells Prompted to Become Patient-Specific Stem Cells
Previously, scientists identified four genes that can transform adult stem cells into induced pluripotent stem cells (iPSCs), which have the capacity to differentiate into specialized cells of the body. However, these genes are delivered by a retrovirus, becoming integrated into the DNA and may, over an extended period of time, activate cancer-causing genes. To overcome this issue, Justin K. Ichida, from Harvard Stem Cell Institute (Massachusetts, USA), and colleagues substituted small chemical molecules for two of the genes, successfully demonstrating an alternative for converting one type of cell into another. The team observes that: “By using a non-biased chemical screening approach, we uncovered a previously unknown way to make stem cells. This discovery is exciting because it demonstrates the feasibility of using chemicals to make safer patient-specific stem cells for transplantation medicine.” Previously, scientists identified four genes that can transform adult stem cells into induced pluripotent stem cells (iPSCs), which have the capacity to differentiate into specialized cells of the body. However, these genes are delivered by a retrovirus, becoming integrated into the DNA and may, over an extended period of time, activate cancer-causing genes. To overcome this issue, Justin K. Ichida, from Harvard Stem Cell Institute (Massachusetts, USA), and colleagues substituted small chemical molecules for two of the genes, successfully demonstrating an alternative for converting one type of cell into another. The team observes that: “By using a non-biased chemical screening approach, we uncovered a previously unknown way to make stem cells. This discovery is exciting because it demonstrates the feasibility of using chemicals to make safer patient-specific stem cells for transplantation medicine.”
Justin K. Ichida, Joel Blanchard, Kelvin Lam, Esther Y. Son, Julia E. Chung, Dieter Egli, Kyle M. Loh, Ava C. Carter, Francesco P. Di Giorgio, Kathryn Koszka, Danwei Huangfu, Hidenori Akutsu, David R. Liu, Lee L. Rubin, Kevin Eggan. “A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog.” Cell Stem Cell, 08 October 2009; doi:10.1016/j.stem.2009.09.012.
Health Headlines
upcoming Events
U.S. Events
congresses
fellowships
-
Aesthetic Medicine Module I
Las Vegas, NV | Dec. 9-10, 2009 -
Anti-Aging & Regenerative Medicine Modules I, II, III & IX
Las Vegas, NV | Dec. 10-12, 2009 -
Preventative Medicine, Nutrition & Sports Medicine Module I
Las Vegas, NV | Dec. 9-11, 2009 -
Fellowship in Preventative Medicine, Nutrition & Sports Medicine Module III
Las Vegas, NV | Dec. 11-12, 2009
symposium
-
Advanced Hormone Symposium
Chicago, IL | Oct. 8-10, 2010
VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health
(PATH Medical), Chairs the
Brain Age Workshop taking place Dec. 9, 2009.
Held in conjunction with the Winter Session of the 17th Annual World
Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies.
The Brain Age Workshop features presentations on Brain Mind Assessment
via Neuropsychological Analysis, Movement Deficiency Syndrome,
Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain
Injury. View this video to learn about Dr. Braverman’s brain-based
model of aging and age modulation.
International Events
- Mexico City | Jan. 15-17, 2010
- Milan | Mar. 18-20, 2010
- Kuala Lumpur | Apr. 29 - May 2, 2010
- Jakarta | May 2010 (pending)
- Bucharest | May 2010 (pending)
- Seoul | May 2010 (pending)
- Melbourne | Aug. 21-22, 2010
- Dubai | Oct. 26-27, 2010
- Bali | October 2010 (pending)
- Mainz-Frankfurt | Nov. 8-10, 2010
- Sao Paulo | Nov. 12-14, 2010
- Shanghai | November 2010 (pending)





